[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
[ Thu, Sep 21st 2023 ]: WOPRAI
Jason Butler Reiterated (AQST) at Buy and Held Target at $8 on, Sep 21st, 2023
- 🞛 This publication is a summary or evaluation of another publication
Jason Butler of JMP Securities, Reiterated "Aquestive Therapeutics, Inc." (AQST) at Buy and Held Target at $8 on, Sep 21st, 2023.
Jason has made no other calls on AQST in the last 4 months.
There is 1 other peer that has a rating on AQST. Out of the 1 peers that are also analyzing AQST, 0 agree with Jason's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jason
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $5 on, Monday, July 31st, 2023